Pfizer Wants Rehearing in Generic Reglan Tardive Dyskinesia Case: Now,...

As Forbes published on February 25th, 2013, Pfizer is asking the Alabama Supreme Court for a rehearing on its ruling that a patient who had only used generic versions of Reglan could sue the...(PRWeb February 27, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10472894.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news